Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1734]

Targeted therapy with pazopanib prolongs progression-free survival in advanced soft-tissue sarcoma

Targeted therapy with pazopanib prolongs progression-free survival in advanced soft-tissue sarcoma

ESTRO 31: HPV-positive throat cancer patients respond better to radiotherapy alone than HPV-negative patients

ESTRO 31: HPV-positive throat cancer patients respond better to radiotherapy alone than HPV-negative patients

Breathing during radiotherapy – how to hit the treatment target without causing collateral damage

Breathing during radiotherapy – how to hit the treatment target without causing collateral damage

ESTRO 31: Highly targeted irradiation as good as whole breast radiotherapy in early stage cancer

ESTRO 31: Highly targeted irradiation as good as whole breast radiotherapy in early stage cancer

Genetic predictor of breast cancer response to chemotherapy

Genetic predictor of breast cancer response to chemotherapy

ESTRO 31: Cheap and simple tool for poor response to radiotherapy caused by low haemoglobin levels

ESTRO 31: Cheap and simple tool for poor response to radiotherapy caused by low haemoglobin levels

ESTRO 31: Stem cell sparing radiotherapy for head and neck cancer may avoid salivary gland damage

ESTRO 31: Stem cell sparing radiotherapy for head and neck cancer may avoid salivary gland damage

Trial transforms thyroid cancer treatment into safer and shorter session

Trial transforms thyroid cancer treatment into safer and shorter session

Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patients

Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patients

ELCC 2012: Promising developments in early diagnosis and treatment of mesothelioma

ELCC 2012: Promising developments in early diagnosis and treatment of mesothelioma

More from ecancer